Health Canada drug identification number

DIN 00742813 — HYDROXYZINE HYDROCHLORIDE INJECTION USP 50 MG

HYDROXYZINE HYDROCHLORIDE INJECTION USP is a liquid of Hydroxyzine marketed by SANDOZ CANADA INCORPORATED. The full Hydroxyzine monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.

DIN
00742813
Brand name
HYDROXYZINE HYDROCHLORIDE INJECTION USP
Active ingredient
Hydroxyzine
Strength
50 MG
Dosage form
LIQUID
Route
INTRAMUSCULAR
Manufacturer
SANDOZ CANADA INCORPORATED
Health Canada status
MARKETED
Drug class
Antihistamine (anxiolytic / antipruritic)

Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.

Other Hydroxyzine products

DINBrandStrengthFormManufacturerStatus
00024694 ATARAX 10 MG SYRUP SEARCHLIGHT PHARMA INC MARKETED
00646059 HYDROXYZINE 10 MG CAPSULE AA PHARMA INC MARKETED
00646024 HYDROXYZINE 25 MG CAPSULE AA PHARMA INC MARKETED
00646016 HYDROXYZINE 50 MG CAPSULE AA PHARMA INC MARKETED
02231209 HYDROXYZINE HYDROCHLORIDE INJECTION, USP 50 MG SOLUTION STERIMAX INC DORMANT
00738824 NOVO-HYDROXYZIN 10 MG CAPSULE TEVA CANADA LIMITED DORMANT
00738832 NOVO-HYDROXYZIN 25 MG CAPSULE TEVA CANADA LIMITED DORMANT
00738840 NOVO-HYDROXYZIN 50 MG CAPSULE TEVA CANADA LIMITED DORMANT

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.